Malaria is still a public health concern in Nigeria and other Sub-Saharan countries. According to the W.H.O, the estimated fatalities stood at 405,000 in 2018, with children under 5 years being major casualties.

The war against malaria is clearly not won, as a 2018 W.H.O report suggests that 6 countries accounted for more than half of all malaria cases worldwide, Nigeria (25%), Democratic Republic of Congo(12%), Uganda (5%), and Cote d’ Ivoire, Niger and Mozambique (4%).

This suggests that more work needs to be done. It is not all gloom, as victory definitely in sight.

The menace of counterfeit malaria drugs in treating malaria is a major cause of the high mortality rates in Nigeria. People not being able to distinguish between counterfeit and authentic malaria drugs is a big source of worry.

Thankfully, Pharmaceutical giant, Greenlife Pharmaceuticals, makers of P-Alaxin, is at the forefront in the war against not just malaria but also counterfeit drugs.
[ad]
They have introduced a mobile system that allows customers, patients, and health practitioners to recognize counterfeit P-Alaxin drugs. One can now identify authentic from counterfeit P-Alaxin drugs by scratching the foil on the pack which reveals a code. Send the revealed code to a number and instantly confirm the authenticity on your mobile phone.

This is a major step in winning the war against malaria in Nigeria.

P-Alaxin has taken the fight against malaria a notch higher by using its platforms to sensitize the public on the prevention, transmission, and treatment of malaria.
[ad]
With the other programmes, collaborations, and efforts by the Government such as distribution and subsidized insecticide-treated nets, indoor spraying, sensitization on malaria prevention, etc. We are gradually nearing the end of the malaria scourge in Nigeria.

To know more about how P-Alaxin is winning the war against malaria. Visit P-Alaxin on all its digital platforms.